KATHERINE REYNOLDS: Open Payments
NPI 1114585346 · SPOKANE VALLEY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,110 in 106 payments from 21 companies in 2025. Trend: 2023 $923 · 2024 $2,432 · 2025 $2,110
Food & beverage: $1,957Education: $153
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $433 |
| Actelion Pharmaceuticals US, Inc. | 14 | $308 |
| GlaxoSmithKline, LLC. | 24 | $234 |
| United Therapeutics Corporation | 7 | $177 |
| GENZYME CORPORATION | 10 | $158 |
| Insmed, Inc. | 4 | $137 |
| Merck Sharp & Dohme LLC | 3 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Amgen Inc. | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
Products named: DUPIXENT, TEZSPIRE, OPSUMIT, FASENRA, AIRSUPRA, TRELEGY ELLIPTA, NUCALA, Arikayce.
Industry payments across WA — which companies pay providers there.
